Pluristem gains FDA approval for new manufacturing plant in Israel

03/10/2014 | Globes (Israel)

The FDA has granted Pluristem Therapeutics approval to use its new manufacturing plant in Haifa, Israel, allowing it to take part in advanced clinical studies in the U.S. The facility features the company's fully automated 3D cell expansion platform for manufacturing stem cells.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations